Top Markets
#1 Zora Zora +31.09%
#2 Tutorial Tutorial +28.83%
#3 GALA GALA +25.38%
#4 Fabric Protocol Fabric Protocol +24.31%
#5 Pieverse Pieverse +23.14%
#6 Arowana Arowana +22.11%
#7 Derive Derive +21.73%
#8 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +20.51%
#9 Bitcoin Cash Bitcoin Cash +20.00%
#10 wojak wojak +19.94%
Coin of the day
Zora Zora
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Orexo AB Orexo AB

Orexo AB

ORX
Classement en actions #24894
Orexo AB (publ), a specialty pharmaceutical company, develops and... Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
Prix de l'action
$1.58
Capitalisation boursière
$55.40M
Changement (1 jour)
0.71%
Changement (1 an)
-28.43%
Pays
SE
Échange Orexo AB (ORX)

Catégorie

Healthcare
Ratio P/S pour Orexo AB (ORX)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Orexo AB, le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Orexo AB de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
10.24 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
14.89 -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
2.29 -
HK